Feng J - Search Results

1

[Relationship between BIM gene polymorphism and therapeutic efficacy in the retreatment of advanced non-small cell lung cancer with tyrosine kinase inhibitor].

Zheng L, Lin B, Song Z, Xie F, Hong W, Feng J, Shao L, Zhang Y. Zheng L, et al. Among authors: feng j. Zhongguo Fei Ai Za Zhi. 2013 Dec;16(12):632-8. doi: 10.3779/j.issn.1009-3419.2013.12.03. Zhongguo Fei Ai Za Zhi. 2013. PMID: 24345487 Free PMC article. Clinical Trial. Chinese.

2

[The killing effect of rmhTNF-alpha combined with gemcitabine on human lung adenocarcinoma cells A549.].

Gu C, Zhang Y, Feng J, Ma S, Lu Y, Hong D, Chen J. Gu C, et al. Among authors: feng j. Zhongguo Fei Ai Za Zhi. 2008 Aug 20;11(4):495-9. doi: 10.3779/j.issn.1009-3419.2008.04.004. Zhongguo Fei Ai Za Zhi. 2008. PMID: 20735956 Free article. Chinese.

3

Effect of adjuvant magnetic fields in radiotherapy on non-small-cell lung cancer cells in vitro.

Feng J, Sheng H, Zhu C, Jiang H, Ma S. Feng J, et al. Biomed Res Int. 2013;2013:657259. doi: 10.1155/2013/657259. Epub 2013 Oct 10. Biomed Res Int. 2013. PMID: 24224175 Free PMC article.

4

Paris saponin I induces apoptosis via increasing the Bax/Bcl-2 ratio and caspase-3 expression in gefitinib-resistant non-small cell lung cancer in vitro and in vivo.

Jiang H, Zhao PJ, Su D, Feng J, Ma SL. Jiang H, et al. Among authors: feng j. Mol Med Rep. 2014 Jun;9(6):2265-72. doi: 10.3892/mmr.2014.2108. Epub 2014 Apr 2. Mol Med Rep. 2014. PMID: 24718383

5

The impact of functional LIG4 polymorphism on platinum-based chemotherapy response and survival in non-small cell lung cancer.

Jiang YH, Xu XL, Ruan HH, Xu WZ, Li D, Feng JG, Han QB, Mao WM. Jiang YH, et al. Med Oncol. 2014 May;31(5):959. doi: 10.1007/s12032-014-0959-7. Epub 2014 Apr 11. Med Oncol. 2014. PMID: 24722796

6

Down Expression of FBP1 Is a Negative Prognostic Factor for Non-Small-Cell Lung Cancer.

Sheng H, Ying L, Zheng L, Zhang D, Zhu C, Wu J, Feng J, Su D. Sheng H, et al. Among authors: feng j. Cancer Invest. 2015 May;33(5):197-204. doi: 10.3109/07357907.2015.1020385. Epub 2015 Apr 6. Cancer Invest. 2015. PMID: 25844935

7

S4646 polymorphism in CYP19A1 gene is associated with the efficacy of hormone therapy in early breast cancer.

Shao X, Cai J, Zheng Y, Wang J, Feng J, Huang Y, Shi L, Chen Z, Guo Y, Wang X. Shao X, et al. Among authors: feng j. Int J Clin Exp Pathol. 2015 May 1;8(5):5309-17. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26191232 Free PMC article.

8

The genotype of ribonucleotidereductase M1 -269C > A is associated with the response to platinum-based chemotherapy and as a prognostic biomarker in advanced nonsmall cell lung cancer.

Xu XL, Zhang YP, Fang Y, Su D, Chen W, Feng JG, Li ZP, Mao WM. Xu XL, et al. J Cancer Res Ther. 2015 Aug;11 Suppl 1:C49-55. doi: 10.4103/0973-1482.163839. J Cancer Res Ther. 2015. PMID: 26323924 Free article.

9

Combined Effects of Suberoylanilide Hydroxamic Acid and Cisplatin on Radiation Sensitivity and Cancer Cell Invasion in Non-Small Cell Lung Cancer.

Feng J, Zhang S, Wu K, Wang B, Wong JY, Jiang H, Xu R, Ying L, Huang H, Zheng X, Chen X, Ma S. Feng J, et al. Mol Cancer Ther. 2016 May;15(5):842-53. doi: 10.1158/1535-7163.MCT-15-0445. Epub 2016 Feb 2. Mol Cancer Ther. 2016. PMID: 26839308

10

Epigenetic therapy potential of suberoylanilide hydroxamic acid on invasive human non-small cell lung cancer cells.

Zhang S, Wu K, Feng J, Wu Z, Deng Q, Guo C, Xia B, Zhang J, Huang H, Zhu L, Zhang K, Shen B, Chen X, Ma S. Zhang S, et al. Among authors: feng j. Oncotarget. 2016 Oct 18;7(42):68768-68780. doi: 10.18632/oncotarget.11967. Oncotarget. 2016. PMID: 27634890 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,461 results

Search Page

Filters